To the full analysis
Organon stock: growth
OGNOrganon reported $6.22B in revenue for fiscal 2025, down 2.9% on the prior year, down 1% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−6.3%
per year from 2017 to 2025, per share −6.6%
Earnings (Annual rate)
−24.7%
per year from 2017 to 2025, per share −24.9%
Free cash flow (Annual rate)
−20.4%
per year from 2017 to 2025, per share −20.6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2017 | |
|---|---|---|
| Revenue | −1.0% | −6.3% |
| Revenue per share | −1.4% | −6.6% |
| Earnings | −38.7% | −24.7% |
| Earnings per share | −39.0% | −24.9% |
| Free cash flow | −22.4% | −20.4% |
| Free cash flow per share | −22.7% | −20.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2017 | $10.5B | $1.8B | $3.33B |
| 2018 | $9.78B | $2.15B | $3.59B |
| 2019 | $7.78B | $3.22B | $2.68B |
| 2020 | $6.53B | $2.16B | $1.91B |
| 2021 | $6.3B | $1.35B | $1.97B |
| 2022 | $6.17B | $917M | $431M |
| 2023 | $6.26B | $1.02B | $538M |
| 2024 | $6.4B | $864M | $588M |
| 2025 | $6.22B | $187M | $538M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 17 Apr 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.